NORTH READING, Mass., Nov. 21, 2019 /PRNewswire/ — TraceLink Inc., a network-based platform company with the world’s largest integrated digital supply network, today announced financial and company results for the third quarter of 2019.
Financial growth highlights for Q3 2019 include:
“This quarter, TraceLink continued to help customers around the globe meet critical regulatory requirements, resulting in strong growth in several markets. Beyond that, we also collaborated with companies across the supply chain to help them understand the value that can be realized from their serialization investments by leveraging the power of the TraceLink network,” said Shabbir Dahod, president and CEO, TraceLink. “This is a very exciting time for TraceLink and the industry, as we continue to drive transformation with the announcement of the Digital Network Platform which will be a game-changer, breaking down existing barriers and providing hundreds of thousands of innovators within the industry with the power and insights to dramatically improve patient health.”
Recent Company growth highlights and milestones include:
Additional Resources:
Follow TraceLink:
About TraceLink
TraceLink is a network-based platform company that leverages its digital supply network and digital network platform to bend the supply chain around the patient. Through its industry-leading digital supply network, the TraceLink Digital Network Platform can enable seamless data sharing and process orchestration across the entire healthcare industry, enabling the creation of a real-time, patient-driven supply network. Leading life science companies, hospitals and retail pharmacies trust TraceLink to deliver complete global connectivity, visibility and traceability of pharmaceuticals, ensuring that every patient gets the medicines they need, when they need them, safely and securely. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by Georgian Partners, Willett Advisors LLC, Vulcan Capital, Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content to download multimedia:http://www.prnewswire.com/news-releases/tracelink-proves-continued-success-in-global-customer-and-network-growth-in-q3-2019-300963150.html
SOURCE TraceLink
Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…
ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…
LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Skirball Cultural Center was…
The Veterinary Referral Center of Central Oregon sets a new standard for excellence with a…
- Study demonstrates alpha-synuclein biomarker can be detected in 93-100% of patients with clinically defined…
Arizona’s largest independent multi-specialty provider group uses athenahealth to empower care teams, enhance operational efficiencies,…